Page last updated: 2024-11-06

piperonyl butoxide and Thrombocythemia, Essential

piperonyl butoxide has been researched along with Thrombocythemia, Essential in 1 studies

Thrombocythemia, Essential: A clinical syndrome characterized by repeated spontaneous hemorrhages and a remarkable increase in the number of circulating platelets.

Research Excerpts

ExcerptRelevanceReference
" Piperonyl butoxide also caused essential thrombocythemia with a dose-response relationship."5.29Chronic toxicity studies of piperonyl butoxide in F344 rats: induction of hepatocellular carcinoma. ( Fujitani, T; Oishi, S; Takahashi, O; Tanaka, T; Yoneyama, M, 1994)
" Piperonyl butoxide also caused essential thrombocythemia with a dose-response relationship."1.29Chronic toxicity studies of piperonyl butoxide in F344 rats: induction of hepatocellular carcinoma. ( Fujitani, T; Oishi, S; Takahashi, O; Tanaka, T; Yoneyama, M, 1994)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Takahashi, O1
Oishi, S1
Fujitani, T1
Tanaka, T1
Yoneyama, M1

Other Studies

1 other study available for piperonyl butoxide and Thrombocythemia, Essential

ArticleYear
Chronic toxicity studies of piperonyl butoxide in F344 rats: induction of hepatocellular carcinoma.
    Fundamental and applied toxicology : official journal of the Society of Toxicology, 1994, Volume: 22, Issue:2

    Topics: Animals; Behavior, Animal; Blood Cell Count; Blood Urea Nitrogen; Carcinoma, Hepatocellular; Diet; F

1994